13 October 2024
-
Insights into the BIOSECURE Act
The recently enacted BIOSECURE Act marks a pivotal shift in U.S. biotechnology policy, aimed at safeguarding national security by imposing restrictions on federal contracts and grants to biotechnology companies affiliated with foreign adversaries, particularly those from China. This legislation addresses growing concerns over data security and potential espionage linked to Chinese firms such as BGI…